MBX Corp - MBX Net Assets per Single Share

Public company logo of mbxbio.com (MBX)

This price chart for MBX Biosciences Inc (MBX) helps illustrate the business development model, which relies on US R&D centers while outsourcing peptide production to third-party contractors. The current figure is 8.57. Dependence on external plants is mitigated by strict long-term agreements. Simultaneously, MBX Biosciences Inc (MBX) minimizes risks by developing therapies to correct hormonal imbalances and metabolic disorders of varying prevalence.

Accounting Value of a Share: MBX Biosciences, Inc. (MBX) for 09/14/2024 - 10/28/2026

mbxbio.com - analytical breakdowns and key metrics (MBX)

- price and consensus price forecast:
Stock Quotes MBX Bio|MBX - Broker Consensus Forecast
- market capitalization data:
Market Value MBX Biosciences Inc|MBX - Full Business Value
- book capitalization data:
Book Value per Share MBX Biosciences|MBX - Accounting Value of Company|Market Capitalization to Book Value Ratio mbxbio.com|MBX - Company Total Assets
- debt and liquidity data:
Debt to Equity MBX Biosciences Inc|MBX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity MBX Biosciences|MBX - Company Total Debt|Debts to Book Capitalization MBX Biosciences Inc
Analysis of all company metrics:MBX Bio (MBX)
Signature product of MBX Biosciences

Book value per share reflects the issuer's net asset value minus all liabilities, serving as an objective measure of the company's actual assets. By analyzing the trend of book value per share, investors assess the financial stability of MBX Biosciences Inc (MBX) during its pre-revenue stage and as it prepares to publish Phase 2 clinical trial results for its drug candidates.

Competitor analysis

Ascendis Pharma Inc. (ASND) - Accounting Value per Share|MDGL: Equity per Share|Net Assets per Single Share Corcept Therapeutics (CORT)|rhythmtx.com (RYTM) - Share Book Value|AKRO - Book Value per Share|Accounting Value of a Share Metsera, Inc.|Book Value per Share MLTX|Book Value per Share CRNX (Crinetics Corp)|Net Assets per Single Share NewAmsterdam Pharma|soleno.life - Accounting Value of a Share|FOLD: Net Assets per Single Share|ETNB - Accounting Value per Share|AGIO: Book Value per Share|Book Value per Share Structure Corp|MDXG - Accounting Value per Share|Accounting Value of a Share RZLT|Net Assets per Single Share LXRX (Lexicon Pharmaceuticals, Inc.)|Accounting Value per Share Altimmune Inc (ALT)|AARD: Book Value per Share|SGMT - Net Asset Value per Share|Accounting Value per Share BioAge Labs, Inc. BIOA|BMEA - Book Price of a Share|QNCX: Book Value per Share|Fractyl Health Inc. (GUTS) - Book Value per Share|Book Value per Share vTv Therapeutics, Inc.|Net Assets per Single Share ATPC|Pluri Inc. - Net Assets per Single Share|Net Asset Value per Share SYBX (synlogictx.com)|Net Assets per Single Share Lipocine LPCN|Net Assets per Single Share Matinas BioPharma Holdings, Inc. MTNB|Book Value per Share SPRB (Spruce Biosciences, Inc.)|GLTO: Net Assets per Share|Carmell Corporation - Net Assets per Single Share|LUMO (lumos-pharma.com) - Net Assets per Share|Net Assets per Single Share ONVO|Accounting Value per Share RDUS